A focused telephonic nursing intervention delivers improved adherence to A1c testing by Orr, Patty M. et al.
Thomas Jefferson University
Jefferson Digital Commons
College of Population Health Faculty Papers Jefferson College of Population Health
October 2006
A focused telephonic nursing intervention delivers










Thomas Jefferson University, albert.crawford@jefferson.edu
See next page for additional authors
Let us know how access to this document benefits you
Follow this and additional works at: http://jdc.jefferson.edu/healthpolicyfaculty
Part of the Health Services Research Commons
This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital Commons is a service of Thomas
Jefferson University's Center for Teaching and Learning (CTL). The Commons is a showcase for Jefferson books and journals, peer-reviewed scholarly
publications, unique historical collections from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and
interested readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been accepted for inclusion in
College of Population Health Faculty Papers by an authorized administrator of the Jefferson Digital Commons. For more information, please contact:
JeffersonDigitalCommons@jefferson.edu.
Recommended Citation
Orr, Patty M. ; McGinnis, Matthew A.; Hudson, Laurel R.; Coberley, Sadie S.; Crawford, Albert;
Clarke, Janice L.; and Goldfarb, Neil I., "A focused telephonic nursing intervention delivers improved
adherence to A1c testing" (2006). College of Population Health Faculty Papers. Paper 30.
http://jdc.jefferson.edu/healthpolicyfaculty/30
Authors
Patty M. Orr, Matthew A. McGinnis, Laurel R. Hudson, Sadie S. Coberley, Albert Crawford, Janice L. Clarke,
and Neil I. Goldfarb
This article is available at Jefferson Digital Commons: http://jdc.jefferson.edu/healthpolicyfaculty/30
DISEASE MANAGEMENT
Volume 9, Number 5, 2006
© Mary Ann Liebert, Inc.
A Focused Telephonic Nursing Intervention Delivers
Improved Adherence to A1c Testing
PATTY M. ORR, M.S.N., Ed.D., R.N.,1 MATTHEW A. MCGINNIS, B.S.,1
LAUREL R. HUDSON, M.S.N., R.N.,1 SADIE S. COBERLEY, Ph.D.,1
ALBERT CRAWFORD, Ph.D., M.B.A., M.S.I.S.,2 JANICE L. CLARKE, R.N.,2
and NEIL I. GOLDFARB2
ABSTRACT
Compliance with hemoglobin A1c (A1c) testing is suboptimal despite the clear national rec-
ommendations and guidelines established for care of patients with diabetes. Recent studies
have demonstrated a relationship between participation in a diabetes disease management
(DM) program and improved adherence to A1c testing. A focused intervention study was ini-
tiated to investigate the ability of a DM program to drive improvement in A1c testing. A co-
hort of 36,327 members experienced a statistically significant increase (29%) in A1c testing
while participating in the 6-month focused intervention. This finding demonstrated that a fo-
cused DM intervention is able to deliver improvement in a clinical process metric critical for




DIABETES imposes an enormous health bur-den on the United States every year. In
2002, 18.2 million Americans had diabetes
(6.3% of the population), and the associated
costs totaled $132 billion ($92 billion direct; $40
billion indirect).1 Nationwide efforts are under
way to delay the progression of diabetes and
its complications, thereby reducing these
tremendous costs. Routine hemoglobin A1c
(A1c) testing is an essential component of the
initiatives aimed at reduction of short- and
long-term complications of diabetes.
The medical literature is replete with evi-
dence that improving glycemic control creates
benefits for persons with diabetes by lowering
diabetes-related costs and decreasing short-
and long-term diabetes complications.2–5 The
Diabetes Control and Complications Trial
(DCCT) found that persons receiving intensive
insulin treatment to reach a glycemic goal of
6.05% or less had dramatic relative reductions
in risk for microvascular and neurological end
points, including greater than 70% reduction
for clinically important sustained retinopathy,
56% for laser photocoagulation, 39% for mi-
croalbuminuria, and 60% for confirmed clini-
cal neuropathy. Although they did not reach
statistical significance, specific macrovascular
end points realized an approximate 41% risk
reduction for combined macrovascular events.5
1Healthways, Inc, Nashville, Tennessee.
2Department of Health Policy, Jefferson Medical College, Philadelphia, Pennsylvania.
In an alternate study, it was demonstrated that,
for a person with an A1c value of 6%, succes-
sive 1% increases in A1c resulted in medical ex-
pense increases of approximately 4%, 10%,
20%, and 30%. Moreover, increases in medical
charges for defined inpatient and outpatient
services accelerated as A1c values increased.6
Recognizing the importance of regularly
scheduled A1c testing in the control of diabetes,
the American Diabetes Association (ADA) and
the American College of Endocrinology estab-
lished guidelines regarding frequency of A1c
testing. The American College of Endocrinol-
ogy/American Association of Clinical En-
docrinologists (ACE/AACE) recommends that
an A1c test be performed during an initial as-
sessment and during follow-up assessments,
which should occur at no longer than 3-month
intervals. The ACE/AACE also recommends
that A1c be universally adopted as the primary
method of assessment of glycemic control. The
ACE/AACE target for glycemic control is an
A1c value less than or equal to 6.5%.7 Similarly,
the ADA recommends obtaining an A1c dur-
ing the initial assessment and then routinely as
part of continuing care. The ADA also recom-
mends that A1c be obtained at least twice a year
in patients who are meeting treatment goals
and whose glycemic control is stable. More fre-
quent testing (ie, quarterly assessment) is rec-
ommended for patients whose therapy has
been changed and for patients who are not
meeting treatment and glycemic goals. The
ADA’s target A1c is less than 7%.8
In general, adherence to diabetes standards
of care, such as adherence to A1c testing fre-
quency guidelines, is less than optimal.8,9 Dis-
ease management (DM) programs have a
unique opportunity to provide a solution. As a
chronic, complex condition affecting large
populations, diabetes lends itself to DM strate-
gies. In fact, diabetes is the most frequently 
included condition among DM program offer-
ings. While numerous studies have demon-
strated the ability of DM to decrease A1c lev-
els,3,10 there are few analyses of the impact of
DM on the frequency of A1c testing in a large
population.
Performance of an A1c test at the recom-
mended frequency is essential for establishing
goals to lower A1c levels, thereby improving
diabetes outcomes. Results of recent Health-
ways, Inc. (Nashville, TN) studies of the impact
of interventions on adherence to A1c testing
showed an association between patient partic-
ipation in the diabetes DM program and a mea-
surable improvement in adherence.11 The pur-
pose of this study was to determine the ability
of a focused telephonic intervention to directly
drive improvement in patient adherence to rec-
ommended A1c testing.
METHODS
Diabetes disease management program overview
DM programs were conceived as a means to
work proactively with persons with chronic
conditions, via telephone and mail, to ensure
that their health and wellness needs are met.
DM telephone communications focus on im-
proving each member’s understanding of his
or her condition, and fostering adherence to
standards of care and treatment regimens. The
seven call centers in this study were staffed
with clinicians (ie, Registered Nurses and Reg-
istered Dieticians) who initiated and main-
tained telephonic relationships with DM pro-
gram members. Enrollment in this program
was via an “opt-out” process (ie, persons with
diabetes were automatically enrolled in the DM
program with the right to decline participa-
tion). For a member under the age of 18, the
telephone call was received by a parent or le-
gal guardian unless the member had parental
permission to receive the call directly. Simi-
larly, caregivers could receive telephone calls
on behalf of elderly or disabled members with
the member’s approval
Telephonic member support included sev-
eral types of phone calls, among them intro-
ductory welcome calls, regularly scheduled
care calls based on level of disease severity, and
reminder calls regarding standards of care.
Mail interventions included quarterly newslet-
ters, reminder mailings, and disease-specific
educational materials. An introduction letter
was mailed to both the patient and the corre-
sponding physician. This was followed by a
welcome packet to members with materials ex-
plaining the program in further detail. Once the
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telephonic intervention was implemented, ad-
ditional materials were mailed to members as
needed.
Population identification
From a diabetes DM population drawn from
16 different health plans, members with mod-
erate-to-severe risk of diabetes complications
were identified using a proprietary risk strati-
fication methodology. In general terms, mem-
bers were stratified based upon the severity
and control of their diabetes, and their utiliza-
tion of emergency department and hospital 
resources. Eligibility criteria included (1) calla-
bility (ie, reachable by telephone), (2) enroll-
ment in the DM program for the continuous 12-
month study period, and (3) stratification in the
top half of the population relative to acuity. The
36,327 members who met the eligibility criteria
represented approximately 19.7% of the dia-
betes DM population. The study population
was 48.7% female, and the mean age was 57.29
years.
The focused intervention
When on a routine call with a member in the
population identified above, the clinician re-
viewed the member’s electronic DM records for
evidence of an A1c test being performed in the
previous 6 months. Evidence of an A1c test ex-
ists in the electronic DM record primarily as an
administrative claim obtained from the health
plan. However, in the absence of an adminis-
trative claim for the test, the clinician asked if
the member had received an A1c test in the past
6 months. If the response was positive, the clin-
ician documented this as a self-reported claim
along with the date and results of the test in
the member’s electronic DM record.
If the member had not been tested during the
past 6 months, the clinician initiated a conver-
sation about the importance of A1c testing in
diabetes management, including the recom-
mended frequency of testing. Clinicians re-
ferred to a script to ensure consistency and
completeness of the message conveyed to
members. A specific goal, created with the
member during the conversation (eg, “I will
talk to my doctor about completing an A1c.”),
was subsequently mailed to the member’s
home address. After a 2-week interval, a fo-
cused follow-up phone call was made to check
on the member’s progress in meeting the goal
of obtaining an A1c test. Focused phone calls
were repeated every 2 weeks, integrating with
regularly scheduled care calls when needed,
until the A1c test had been completed or until
the 6-month study period had ended.
Data dollection and analysis
The 6-month preintervention period was de-
fined as September 1, 2003 through February
29, 2004. The 6-month focused intervention pe-
riod included March 1, 2004 through August
31, 2004 (with a 4-month run-out to allow for
the inclusion of late medical claims). A1c test-
ing adherence was determined by evidence of
a test being performed in the electronic DM
record, represented primarily by administra-
tive claims, and secondarily via self-report
from the members. Two subsets of members
were established: (1) those with administrative
claims and (2) those with self-reported claims.
The electronic DM records for the identified
population were evaluated for laboratory
claims and self-reports of an A1c test in the
preintervention and focused intervention peri-
ods. The member records were flagged for each
period with “Y” (evidence of A1c) or “N” (no
evidence of A1c). An adherence percentage
was calculated for each period (ie, total num-
ber of members having an A1c test/total mem-
bers in population). Additional analyses were
performed to measure the A1c testing percent-
ages for members with self-reported A1c tests
compared to members with A1c tests docu-
mented by administrative claims.
Statistical analysis
The results were tested for statistical signifi-
cance using a Z test.
RESULTS
At the completion of the 6-month focused in-
tervention, the aggregate number of members
who received an A1c test increased 12%, from
14,843 to 19,235 members (Fig. 1). This repre-
sented a statistically significant increase in A1c
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testing adherence, from 40.9% to 52.9% (29%
relative increase) for patients in the moderate-
to-severe risk strata for diabetes complications
(p  0.0001, Z  32.651).
Gender appeared to have no impact on ad-
herence to A1c testing. Females experienced a
12.4% improvement (from 41.3% to 53.8%),
whereas males had an 11.8% increase (40.4% to
52.2%) in A1c testing.
Age appeared to influence A1c testing ad-
herence (Fig. 2). The greatest improvement was
observed in the 0–19 age group; within this
group, those aged 0–9 years had a testing in-
crease of 14.9%, and those aged 10–19 years had
an increase of 20.4%. Members aged 50–69 ex-
perienced large increases as well; a 12.7% in-
crease for those aged 50–59 years and a 13.4%
increase for those aged 60–69 years. All other
age categories demonstrated increases in A1c
testing, ranging from 8.1% to 10.6%.
Seventy-two percent of the A1c tests
recorded in the electronic DM record were ac-
quired from administrative claims data. Eval-
uation of testing adherence for members with
self-reported A1c tests compared to members
with A1c tests documented by administrative
claims data revealed similar increases, 5.9%
and 6.6%, respectively, after 6 months of fo-
cused intervention. This improvement in A1C
testing adherence was statistically significant
(p  0.0001, Z  24.632) for both member
groups.
The call differential analysis (ie, the number
of additional calls received by a member in the
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FIG. 1. Improvement in hemoglobin A1c (A1c) adherence across months of the focused intervention. Month zero
shows A1c testing in the last month of the preintervention period.
FIG. 2. Percent increase in hemoglobin A1c (A1c) testing adherence across age groups during the focused inter-
vention period compared to the preintervention period.
focused intervention period when compared to
preintervention) revealed a positive correlation
between incremental increases in the number
of calls and the observed increases in testing
adherence (Fig. 3). The addition of one, two,
three, or four phone calls during the focused
intervention led to corresponding increases in
A1c testing adherence of 14.0%, 16.1%, 17.3%,
and 23.6%, respectively, compared to the prein-
tervention period. 
DISCUSSION
The focused diabetes DM intervention was
associated with significant increases in A1c
testing adherence in a large population (n 
36,327) over a 6-month period. This finding
suggests that a short-term telephonic interven-
tion can positively impact patient adherence to
a clinical process metric relevant to their dia-
betes disease control. The increase in A1c test-
ing also demonstrates the potential for patient
initiation to serve as an effective tool for posi-
tive change in physician performance on stan-
dard-of-care measures. Such results suggest
that DM interventions can encourage patients
to partner with their physicians in managing
their conditions, thus strengthening the pa-
tient/physician relationship.
While no differences were observed with re-
spect to gender in this study, adherence to A1c
testing appeared to be affected by patient age.
Members aged 0–19 years demonstrated the
best improvement (ie, testing compliance in-
creased from 14.9% to 20.4% for this popula-
tion). This may be explained by parental in-
volvement and the assumption that parents of
children with diabetes are particularly recep-
tive to guidance that ensures the health and
safety of their children. Specifically, members
in the aged 10–19 subgroup demonstrated
greater improvement in A1c testing compli-
ance than the total group. This may stem from
the members having parental permission to re-
ceive the intervention calls and to become more
involved in managing their diabetes.
Members aged 50–69 years had the next
largest improvement in A1c testing adherence:
12.7% of those aged 50–59 years and 13.4% of
those aged 60–69 years. While young enough
to actively care for themselves, these members
may be more likely to experience significant
physical and health-related changes, which
may motivate improvements in adherence.
Those members in the age groups 80–89,
90–99, and 30–39 demonstrated improvements
of 9.4%, 8.1%, and 8.6%, respectively. Illness
and frailty may hinder elderly members in tak-
ing the recommended action steps for their
health. For those aged 30–39 years, factors re-
lated to employment and child care may inter-
fere with scheduling and keeping additional
healthcare appointments. Similarly, members
in this age group may be less likely to be at
home to receive focused intervention telephone
calls.
Call differential proved to be an interesting
end point in this study. The results suggest
that increases in the number of phone calls
and goal-setting conversations are associated
with subsequent increases in A1c testing ad-
herence. When compared to the standard
number of calls received in the preinterven-
tion phase, members receiving one, two, three,
or four additional phone calls during the in-
tervention demonstrated steady increases in
adherence as the number of calls and oppor-
tunities for goal setting increased. Longer-
term studies in similar populations might re-
veal the exact nature of this relationship, and
be useful for program design and business
model improvements.
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FIG. 3. Hemoglobin A1c (A1c) adherence improve-
ment–call differential comparison. Members who re-
ceived one to four more calls during the focused inter-
vention period compared to the preintervention period
had higher A1c testing adherence.
In general, this study supports the hypothe-
sis that improvement in clinical process metrics
in a large population can be driven by a DM
program, in this case by a focused telephonic
nursing intervention. Evidence of the ability to
impact enormous numbers of individuals in a
relatively short time is encouraging, not just for
the DM industry, but for the care of diabetes
populations as a whole.
Limitations
Data collection. This research examined both
administrative medical claims and self-reports
to determine A1c testing adherence. Although
select studies have indicated that persons with
diabetes can accurately report whether or not
they have received an A1c test in the past
year,12 other studies indicate that self-reports
of A1c tests overstate reality.13 Future studies
might investigate the accuracy of self-reports
by following A1c adherence in a group of mem-
bers with administrative claims data for their
ability to accurately report the performance of
an A1c test.
Length of study period. To fully understand the
effect of DM programs on A1c testing adher-
ence, future studies might be designed to ana-
lyze the longer-term impact of such an inter-
vention on a diabetes population. For instance,
a longer study period might allow an examina-
tion of whether the intervention produced only
short-term adherence (ie, members obtained one
A1c test during the 6-month study period) or a
sustained behavior change (ie, members contin-
ued to obtain tests as often as recommended). A
longer study period also will be important in as-
sessing the relationship between contact with
members by telephone (ie, calls), setting goals,
and driving improvement in outcomes.
Generalizability. While drawn from 16 differ-
ent health plans in different regions of the
United States, the population studied herein
had diabetes severity scores ranging from mod-
erate to severe according to a proprietary risk
stratification model. Because of the higher bur-
den of disease, these members may be more
likely to be at home to receive the intervention
phone calls. Specifically, their illness may in-
terfere with their ability to be employed full-
time or otherwise out of the home. A combi-
nation of unmeasured variables may influence
the particular receptivity of this population to
the intervention program, including the aver-
age adherence rate prior to the intervention
(low vs. high), the type of metric under con-
sideration, and the disease population of inter-
est. The potential effects of these additional
variables undermine the ability to extrapolate
these results to a larger, more generic chroni-
cally ill population.
Future research
Future study designs might take into con-
sideration the limitations noted above and will
include:
• Randomizing the population into a focused
intervention DM group and a standard DM
control group for comparison
• Constructing analyses that examine the rela-
tionship between adherence to testing and
outcomes (ie, clinical values, disease control,
and costs)
• Lengthening the intervention duration to 12
or more months
CONCLUSION
To date, few studies have examined the po-
tential of DM to improve clinical process met-
rics across large populations of chronically ill
individuals. This study suggests that this fo-
cused DM intervention is associated with in-
creased adherence to A1c testing guidelines in
a large diabetes population. In addition, these
findings suggest that, equipped with the ap-
propriate knowledge and communication
skills, patients can contribute toward improv-
ing their adherence to recognized standards of
care. This study provides a foundation for a va-
riety of similar studies to investigate the spe-
cific role of DM programs in empowering pa-
tients to improve their health. 
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